EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia. (Q43486412)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

title

EVI-1 modulates leukemogenic potential and apoptosis sensitivity in human acute lymphoblastic leukemia (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Claudia Lengerke

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

Martina Konantz

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

author name string

M C André

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

M Grauer

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

H Wang

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Grzywna

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

O C Rothfuss

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

S Lehle

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

O S Kustikova

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

H R Salih

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

R Handgretinger

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

F Fend

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

C Baum

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

L Kanz

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

L Quintanilla-Martinez

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

K Schulze-Osthoff

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

F Essmann

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

language of work or name

1 reference

25 July 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

volume

27

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

8 February 2020

page(s)

56-65

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22828445%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/leu.2012.211

8 February 2020

exact match

0 references

cites work

Identification of a common ecotropic viral integration site, Evi-1, in the DNA of AKXD murine myeloid tumors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Trib1 and Evi1 cooperate with Hoxa and Meis1 in myeloid leukemogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

EVI-1 oncogene expression predicts survival in chronic-phase CML patients resistant to imatinib treated with second-generation tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Prognostically useful gene-expression profiles in acute myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

The transcription factor Evi-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

The oncogene and developmental regulator EVI1: expression, biochemical properties, and biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

The Evi1 proto-oncogene is required at midgestation for neural, heart, and paraxial mesenchyme development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Evi-1 is a critical regulator for hematopoietic stem cells and transformed leukemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Oncogenic transcription factor Evi1 regulates hematopoietic stem cell proliferation through GATA-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Four of the seven zinc fingers of the Evi-1 myeloid-transforming gene are required for sequence-specific binding to GA(C/T)AAGA(T/C)AAGATAA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

The corepressor CtBP interacts with Evi-1 to repress transforming growth factor beta signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

The oncoprotein Evi-1 represses TGF-beta signalling by inhibiting Smad3

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

EVI1 recruits the histone methyltransferase SUV39H1 for transcription repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

A novel interaction between the proto-oncogene Evi1 and histone methyltransferases, SUV39H1 and G9a

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

The leukaemia-associated transcription factors EVI-1 and MDS1/EVI1 repress transcription and interact with histone deacetylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

EVI1 is consistently expressed as principal transcript in common and rare recurrent 3q26 rearrangements.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Screening for EVI1: ectopic expression absent in T-cell acute lymphoblastic leukemia patients and cell lines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Microarray-based classification of a consecutive series of 121 childhood acute leukemias: prediction of leukemic and genetic subtype as well as of minimal residual disease status.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Aberrant expression of the homeobox gene CDX2 in pediatric acute lymphoblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Molecular response to treatment redefines all prognostic factors in children and adolescents with B-cell precursor acute lymphoblastic leukemia: results in 3184 patients of the AIEOP-BFM ALL 2000 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Efficient shRNA delivery into B and T lymphoma cells using lentiviral vector-mediated transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Polyclonal fluctuation of lentiviral vector-transduced and expanded murine hematopoietic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Low expression of MDS1-EVI1–like-1 (MEL1) and EVI1-like-1 (EL1) genes in favorable-risk acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Quantitative comparison of the expression of EVI1 and its presumptive antagonist, MDS1/EVI1, in patients with myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

21 January 2018

IAPs: what's in a name?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Human lymphoid and myeloid cell development in NOD/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Comparison of human cord blood engraftment between immunocompromised mouse strains

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Engraftment of human hematopoietic stem cells is more efficient in female NOD/SCID/IL-2Rgc-null recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Leukemia-initiating cells in human T-lymphoblastic leukemia exhibit glucocorticoid resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Humanized model to study leukemic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

High frequencies of leukemia stem cells in poor-outcome childhood precursor-B acute lymphoblastic leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Early Relapse in ALL Is Identified by Time to Leukemia in NOD/SCID Mice and Is Characterized by a Gene Signature Involving Survival Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

The evi-1 oncoprotein inhibits c-Jun N-terminal kinase and prevents stress-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Evi1 is a survival factor which conveys resistance to both TGFbeta- and taxol-mediated cell death via PI3K/AKT

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Evaluation of EVI1 and EVI1s (Delta324) as potential therapeutic targets in ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

DNA damage-induced cell death by apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Acetylation of the proto-oncogene EVI1 abrogates Bcl-xL promoter binding and induces apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Arsenic trioxide and thalidomide combination produces multi-lineage hematological responses in myelodysplastic syndromes patients, particularly in those with high pre-therapy EVI1 expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

EVI1 induces myelodysplastic syndrome in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

High EVI1 expression predicts outcome in younger adult patients with acute myeloid leukemia and is associated with distinct cytogenetic abnormalities

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

Expression of the Evi-1 gene in haemopoietic cells of children with juvenile myelomonocytic leukaemia and normal donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

EVI-1 gene expression in myeloid clonogenic cells from juvenile myelomonocytic leukemia (JMML)

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

EVI-1 interacts with histone methyltransferases SUV39H1 and G9a for transcriptional repression and bone marrow immortalization

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

Distinct gene expression profiles determine molecular treatment response in childhood acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

Large but not small copy-number alterations correlate to high-risk genomic aberrations and survival in chronic lymphocytic leukemia: a high-resolution genomic screening of newly diagnosed patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

A comprehensive antibody panel for immunohistochemical analysis of formalin-fixed, paraffin-embedded hematopoietic neoplasms of mice: analysis of mouse specific and human antibodies cross-reactive with murine tissue

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

Evi-1 is a transcriptional target of mixed-lineage leukemia oncoproteins in hematopoietic stem cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021

Leukemia induction after a single retroviral vector insertion in Evi1 or Prdm16

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.211

7 January 2021